Risk factors and prevention of cardiotoxicity induced by 5-fluorouracil or capecitabine

By Jensen Søren   Sørensen Jens  

Cancer Chemotherapy and Pharmacology, Vol. 58, Iss. 4, 2006-10 ,pp. : 487-493

Springer Publishing Company

Access to resources Recommend Favorite

Cetuximab and irinotecan as third line therapy in patients with advanced colorectal cancer after failure of irinotecan, oxaliplatin and 5-fluorouracil

By Pfeiffer Per   Nielsen Dorte   Yilmaz Mette   Iversen Anja   Vejlø Christian   Jensen Benny Vittrup  

Acta Oncologica, Vol. 46, Iss. 5, 2007-01 ,pp. : 697-701

Informa Healthcare

Access to resources Recommend Favorite

Inhibitory effects and mechanism of 5-fluorouracil combined with celecoxib on human gastric cancer xenografts in nude mice

By  

Experimental and Therapeutic Medicine, Vol. 9, Iss. 1, 2015-01 ,pp. : 105-111

Spandidos Publications

Access to resources Recommend Favorite

Functional mechanism of the enhancement of 5fluorouracil sensitivity by TUSC4 in colon cancer cells

By              

Oncology Letters, Vol. 10, Iss. 6, 2015-01 ,pp. : 3682-3688

Spandidos Publications

Access to resources Recommend Favorite

Autoregulation of 5-fluorouracil metabolism

By McLeod H.L.   Sludden J.   Hardy S.C.   Lock R.E.   Hawksworth G.M.   Cassidy J.  

European Journal of Cancer, Vol. 34, Iss. 10, 1998-09 ,pp. : 1623-1627

Elsevier

Access to resources Recommend Favorite